College of Pharmacy, Dalhousie University, Halifax, Nova Scotia, Canada.
Pharmacy Department Halifax Infirmary, Nova Scotia Health, Halifax, Nova Scotia, Canada.
Ann Pharmacother. 2023 Jul;57(7):837-846. doi: 10.1177/10600280221133078. Epub 2022 Oct 31.
To provide pharmacists and other health care professionals with the knowledge required to minimize the risk of prolonged opioid use following total hip arthroplasty (THA) and total knee arthroplasty (TKA).
A literature search of PubMed and Embase was performed, and included the search terms: (opioid OR opiate OR opium) AND (risk factor OR predict*) AND (arthroplasty OR replacement) NOT shoulder.
Randomized control trials, cohort studies (both prospective and retrospective), systematic reviews, and meta-analyses were included if risk ratios (RRs) or odds ratios (ORs) were reported and published within the last 5 years.
]Twenty studies met inclusion criteria, including 2 meta-analyses and 2 prospective studies. There were several risk factors that overlapped between studies and presented clinically significant risks for prolonged opioid use following THA and TKA surgery. Of these, age < 65 (RRs: 1.15-9.36), preoperative opioid use (RRs: 1.09-7.81), larger quantities of opioids prescribed at discharge (RRs: 1.26-8.81), and TKA surgery (RRs: 1.73-6.07) were the most significant. Several risk factors were recently described, including migraines (RRs: 1.14-5.11) and fibromyalgia (RRs: 1.1-2.3) that may be of interest for further research.
This review presents a discussion of the factors associated with prolonged opioid use following THA and TKA surgeries, which are among the most common orthopedic surgeries.
Prescribers should carefully consider patient-specific factors when prescribing opioids as there are several factors, including age, surgery type, and medical conditions that can predispose patients to prolonged opioid use.
为药剂师和其他医疗保健专业人员提供相关知识,以尽量降低全髋关节置换术(THA)和全膝关节置换术(TKA)后长期使用阿片类药物的风险。
对 PubMed 和 Embase 进行文献检索,检索词包括:(阿片类药物或鸦片类药物或阿片)和(风险因素或预测*)和(关节置换术或置换术),不包括肩部。
如果报告了风险比(RR)或比值比(OR),并且在过去 5 年内发表,则纳入随机对照试验、队列研究(前瞻性和回顾性)、系统评价和荟萃分析。
有 20 项研究符合纳入标准,包括 2 项荟萃分析和 2 项前瞻性研究。有几个风险因素在研究中重叠,并对 THA 和 TKA 手术后长期使用阿片类药物呈现出显著的临床风险。其中,年龄<65 岁(RR:1.15-9.36)、术前使用阿片类药物(RR:1.09-7.81)、出院时开具的阿片类药物剂量较大(RR:1.26-8.81)和 TKA 手术(RR:1.73-6.07)是最显著的。最近还描述了一些风险因素,包括偏头痛(RR:1.14-5.11)和纤维肌痛(RR:1.1-2.3),这可能值得进一步研究。
本综述讨论了与 THA 和 TKA 手术后长期使用阿片类药物相关的因素,这些手术是最常见的骨科手术之一。
在开具阿片类药物时,医生应仔细考虑患者的具体情况,因为有几个因素,包括年龄、手术类型和疾病状况,可能使患者容易长期使用阿片类药物。